Drug Trial Radar · NCT05118542
Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
Last checked: Nov 20, 2026Latest source record: Nov 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Jan 1, 2019
Primary completion
Jun 1, 2020
Study completion Aug 1, 2020
Sponsor
- Lead sponsor
- Universitas IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 12, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
During July 2019 to August 2020, a single-blind clinical trial was done to 36 patients with Graves' disease. At the beginning of the study, subjects were accommodated into 2 groups, 17 into PTU groups and 19 into methimazole groups. There were 24 subjects who finished the study, 13 from PTU group and 11 from methimazole group. Blood serum was collected for HOMA-IR, LDL-R, NFĸB, sICAM-1, sVCAM-1 and sE-selectin examination. Meanwhile stiffness and thickness of carotid artery was measured using PWV and cIMT.
Conditions
- Hyperthyroidism
- Graves Disease
- Atherosclerosis of Artery
- Pathophysiology
Interventions
PropylthiouracilDrug
PTU were given to participants with adjusted dosage according to patient clinical assessment at every visit by their own endocrinologist.
MethimazoleDrug
methimazole were given to participants with adjusted dosage according to patient clinical assessment at every visit by their own endocrinologist.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pulse Wave VelocityTime frame: Change from Baseline to 3 month follow-up
- carotid intima media thicknessTime frame: Change from Baseline to 3 month follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Indonesia
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.